- Reports /
- Flea and Tick Product Market
Flea and Tick Product Market
Flea and Tick Product Market Market Research Report – Segmented By Product (Oral Pill, Spray, Spot On, Powder, Shampoo, Collar, Other Products (Injection, Drops, and Dips)), By Animal (Dog, Cat, Other Animals (Mice, Rabbits, etc.)) & Region (North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America) – Analysis on Size, Share, Trends, COVID-19 Impact, Competitive Analysis, Growth Opportunities and Key Insights from 2019 to 2027.
Table of contents
- Executive Summary
- Market Overview
- Industry Analysis
- Market Analysis
- By Product
- By Animal
- North America
- Europe
- Asia-Pacific
- Middle-East & Africa
- Latin America
- Company Analysis
- Competitive Analysis
- Research Methodology
- Appendix
Executive Summary
Flea and Tick Product Market was valued at US $6.42 billion in 2021 and is projected to grow at 10.73% CAGR over the forecast period to reach US $11.83 billion by 2027. Flea and Tick Product Market represented US $1.18 billion opportunity over 2019-2021 and estimated to create US $5.41 billion opportunity in 2027 over 2021.
Flea and Tick Product from Consainsights analyses the Flea and Tick Product Market in the Life Sciences industry over the forecast period to 2027.
Flea and Tick Product research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.
Flea and Tick Product segmentation includes Product, Animal and Geography.
Based on the Product, the Flea and Tick Product analysis covers Oral Pill, Spray, Spot On, Powder, Shampoo, Collar, Other Products (Injection, Drops, and Dips).
In Product segment, Oral Pill segment has highest cagr growth of 9.48%.
Based on the Animal, the Flea and Tick Product analysis covers Dog, Cat, Other Animals (Mice, Rabbits, etc.).
In Animal segment, Dog segment has highest cagr growth of 9.48%.
Based on the region, the Flea and Tick Product analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.
Key companies operating in the market include Zoetis Inc., Ceva, Ecto Development Corporation, Elanco, Merck Inc. (Intervet Inc.), Boehringer Ingelheim, Sergeant's Pet Care Products Inc., The Hartz Mountain Corporation, Virbac and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.
Market Overview
Definition & Scope
The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.
The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.
The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.
Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.
Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.
As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.
Currency, Year & Forecast
The currency used in this report is USD, with the market size indicated in terms of USD million/billion.
For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.
For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.
Product
Introduction
In 2021, Oral Pill segment has the highest revenue of US $2.51 billion and is expected to grow at CAGR of 9.48% by 2027 Oral Pill segment has highest cagr growth of 9.48%.
Oral Pill
Oral Pill segment was valued at US $2.04 billion in 2019 and is projected to grow at 9.48% CAGR over the forecast period to reach US $4.62 billion by 2027. Oral Pill segment represented US $0.46 billion opportunity over 2019-2021 and estimated to create US $2.11 billion opportunity in 2027 over 2021.
Spray
Spray segment was valued at US $1.20 billion in 2019 and is projected to grow at 9.48% CAGR over the forecast period to reach US $2.72 billion by 2027. Spray segment represented US $0.27 billion opportunity over 2019-2021 and estimated to create US $1.24 billion opportunity in 2027 over 2021.
Spot On
Spot On segment was valued at US $0.86 billion in 2019 and is projected to grow at 9.48% CAGR over the forecast period to reach US $1.93 billion by 2027. Spot On segment represented US $0.19 billion opportunity over 2019-2021 and estimated to create US $0.88 billion opportunity in 2027 over 2021.
Powder
Powder segment was valued at US $0.53 billion in 2019 and is projected to grow at 9.48% CAGR over the forecast period to reach US $1.20 billion by 2027. Powder segment represented US $0.12 billion opportunity over 2019-2021 and estimated to create US $0.55 billion opportunity in 2027 over 2021.
Shampoo
Shampoo segment was valued at US $0.31 billion in 2019 and is projected to grow at 9.48% CAGR over the forecast period to reach US $0.70 billion by 2027. Shampoo segment represented US $0.07 billion opportunity over 2019-2021 and estimated to create US $0.32 billion opportunity in 2027 over 2021.
Collar
Collar segment was valued at US $0.13 billion in 2019 and is projected to grow at 9.48% CAGR over the forecast period to reach US $0.29 billion by 2027. Collar segment represented US $0.03 billion opportunity over 2019-2021 and estimated to create US $0.13 billion opportunity in 2027 over 2021.
Other Products (Injection, Drops, and Dips)
Other Products (Injection, Drops, and Dips) segment was valued at US $0.17 billion in 2019 and is projected to grow at 9.48% CAGR over the forecast period to reach US $0.37 billion by 2027. Other Products (Injection, Drops, and Dips) segment represented US $0.04 billion opportunity over 2019-2021 and estimated to create US $0.17 billion opportunity in 2027 over 2021.
Animal
Introduction
In 2021, Cat segment has the highest revenue of US $2.71 billion and is expected to grow at CAGR of 9.48% by 2027 Dog segment has highest cagr growth of 9.48%.
Dog
Dog segment was valued at US $1.78 billion in 2019 and is projected to grow at 9.48% CAGR over the forecast period to reach US $4.03 billion by 2027. Dog segment represented US $0.40 billion opportunity over 2019-2021 and estimated to create US $1.84 billion opportunity in 2027 over 2021.
Cat
Cat segment was valued at US $2.21 billion in 2019 and is projected to grow at 9.48% CAGR over the forecast period to reach US $4.99 billion by 2027. Cat segment represented US $0.50 billion opportunity over 2019-2021 and estimated to create US $2.28 billion opportunity in 2027 over 2021.
Other Animals (Mice, Rabbits, etc.)
Other Animals (Mice, Rabbits, etc.) segment was valued at US $1.25 billion in 2019 and is projected to grow at 9.48% CAGR over the forecast period to reach US $2.82 billion by 2027. Other Animals (Mice, Rabbits, etc.) segment represented US $0.28 billion opportunity over 2019-2021 and estimated to create US $1.29 billion opportunity in 2027 over 2021.